Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.84 USD | -1.31% | -1.26% | +17.39% |
May. 13 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.39% | 1.53B | |
+39.82% | 731B | |
+31.34% | 586B | |
-7.31% | 348B | |
+14.23% | 319B | |
+0.86% | 273B | |
+13.47% | 235B | |
-6.63% | 203B | |
+7.49% | 202B | |
+4.51% | 159B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Barclays Adjusts Price Target on Ligand Pharmaceuticals to $150 From $157, Reiterates Overweight Rating